# BI 6727 (Volasertib) Human ADME Trial in Various Solid Tumours

> **NCT01145885** · PHASE1 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 7 (actual)

## Conditions studied

- Neoplasms

## Interventions

- **DRUG:** BI 6727

## Key facts

- **NCT ID:** NCT01145885
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-06
- **Primary completion:** 2010-11
- **Final completion:** 2010-11
- **Target enrollment:** 7 (ACTUAL)
- **Last updated:** 2019-01-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01145885

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01145885, "BI 6727 (Volasertib) Human ADME Trial in Various Solid Tumours". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT01145885. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*